Alpha Capital Anstalt v. BriaCell Therapeutics Corp.: Complaint

Complaint in Alpha Capital Anstalt, of Liechtenstein v. BriaCell Therapeutics Corp., a Canadian company that “describes itself as “clinical-stage biotechnology company specializing in targeted immunotherapies for advanced breast cancer” and whose shares are listed on NASDAQ and the Toronto Stock Exchange, at the Supreme Court of the State of New York, County of New York.